Screening Library

Screening Library of 250,000 small molecules

Evotec’s screening library is designed and managed to provide high quality hits that will reduce downstream costs. Evotec’s screening library is differentiated from other screening libraries through quality, diversity and novelty. Evotec constantly analyses the quality of each compound in the library to ensure that it meets stringent quality criteria prior to entering a screen thus eliminating any potential false positives or false negatives and reducing downstream costs for the partner. In addition, new chemotypes are constantly added to the library to ensure that it is diverse and novel with respect to screening.

Evotec also provides access to a library of 30,000 fragments for screening using its fragment based drug discovery platform, EVOlution^SM.

For more information, please contact us at info@evotec.com

Further Information

Assay Development & Screening.pdf
(pdf - 520,11 kB)

Screening Library.pdf
(pdf - 75,88 kB)

Fragment-based Drug Discovery.pdf
(pdf - 876,2 kB)

Ion Channel Drug Discovery.pdf
(pdf - 876,56 kB)

High Content Screening.pdf
(pdf - 195,3 kB)

GPCR Drug Discovery.pdf
(pdf - 187,45 kB)

February 11, 2012
05:09 AM CET